Clinical Trials Logo
  1. Home
  2. High Risk Pregnancy
  3. NCT01708746

Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views

High Risk Pregnancy Clinical Trial

Clinical Trial Summary

This is a prospective, single-institution observational study to be conducted at 4 clinics within the Southern California Permanente Medical Group. Pregnant women who present for prenatal genetic counseling at the designated clinics and who meet study eligibility criteria will be offered the option of the verifi® prenatal test by a trained, licensed and certified genetic counselor (GC) . Women who elect the verifi® prenatal test will have a blood sample drawn by peripheral venipuncture that will be sent to the Verinata Health CAP-accredited clinical laboratory (Redwood City, CA). Results will be reported to the ordering health care provider by the laboratory within 8-10 business days and will be shared with the subject by their provider. Subject care and decision-making following NIPT result will be clinically managed by the provider with his/her subject and is not dictated by the study protocol. All eligible women who provide informed consent, whether they elect or decline NIPT will be asked to complete a short questionnaire on their views of prenatal testing. The uptake of invasive prenatal procedures (CVS and/or amniocentesis) by the total prospective cohort will be collected through review of electronic medical records (EMR). A historical cohort with matched demographic and pre-test indications to the prospective cohort will be identified from the EMR for comparison in the primary analysis.

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01708746
Study type Observational
Source Verinata Health, Inc.
Contact
Status Completed
Phase N/A
Start date November 2012
Completion date October 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT02627482 - Ambulatory Fetal Heart Rate Monitoring in Small Babies N/A
Active, not recruiting NCT03904979 - Therapeutic Writing to Reduce Stress N/A
Completed NCT02749851 - Placenta Imaging Project
Completed NCT03772080 - Prematurity Education in High Risk Pregnancies N/A
Recruiting NCT06151613 - Continuous Non-invasive Electrophysiological Monitoring in High Risk Pregnancies N/A
Enrolling by invitation NCT05763069 - HOME: Home Monitoring of High-risk Pregnancies
Not yet recruiting NCT04173559 - Sleep and Tracking Effects in Pregnancy Study N/A
Recruiting NCT03152058 - IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy Phase 2
Not yet recruiting NCT06320054 - Preventing Obstetric Complications With Dietary Intervention N/A
Recruiting NCT03220750 - University Hospital Advanced Age Pregnant Cohort N/A
Not yet recruiting NCT04855513 - Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial N/A
Completed NCT03082664 - Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients N/A
Recruiting NCT06279559 - Music Therapy and High-risk Pregnancy N/A
Not yet recruiting NCT05479357 - Carbetocin Versus Oxytocin for Prophylaxis Against Atonic Primary Post-partum Hemorrhage N/A
Recruiting NCT04203082 - Cognitive Behavioral Intervention to Reduce Procedural Anxiety Among Woman With High Risk Pregnancies With Scheduled Cesarean Deliveries N/A
Completed NCT02379351 - Use Of An In-Home Non-Stress Test Device For Remote Fetal Monitoring N/A
Recruiting NCT04783597 - Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies
Recruiting NCT06130150 - Sexual Function in High-risk Pregnant Women
Recruiting NCT03775954 - Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Suspended NCT02838030 - Efficacy of Aspirin and L-arginine in High Risk Preeclamptic Phase 2